GVS GVS: insider trades · Italy · Consob

About GVS GVS

GVS S.p.A. is an Italian industrial group specialized in high-technology filtration and separation solutions. Listed on Borsa Italiana (FTSE MIB) in Italy, the company operates in markets where reliability, compliance and performance are critical, notably healthcare, laboratories, industry and, more broadly, safety- and mobility-related applications. Its corporate headquarters are in Bologna, and the company was founded in Italy in 1979, originally to support the pharmaceutical business. Since then, GVS has expanded from a specialist healthcare supplier into a global player in filtration technologies. The group emphasizes more than 40 years of history, a strong commitment to research, development and innovation, and a “glocal” operating model that combines local customer proximity with an international industrial footprint. GVS currently operates 18 manufacturing plants, 30 commercial offices and 10 R&D centers across Europe, North America, South America and Asia. Its activities are organized into five divisions: MedTech, Transfusion Medicine, Life Sciences, Safety and Energy & Mobility. This structure allows the group to address a broad range of applications, from medical devices and extracorporeal circuits to laboratory filtration, respiratory protection and energy/mobility uses. Key products and solutions include drug delivery systems, blood treatment products, respiratory and anesthesia systems, laboratory filtration and customized OEM solutions. In competitive terms, GVS is positioned as a global manufacturer of advanced filtration solutions for highly critical applications, supported by diversified manufacturing, product specialization and a meaningful innovation pipeline. The company’s sales are highly international, with significant exposure to North America and Europe. Recent highlights include May 2026 quarterly results showing growth at constant exchange rates and a reaffirmation of 2026 guidance. Shareholders also renewed the board, confirming Massimo Scagliarini as CEO. For investors, GVS stands out as a niche industrial name with a strong healthcare angle, global reach and a mix of defensive characteristics and operational sensitivity to foreign exchange, supply chain conditions and energy inputs.